Journal of Inflammatory Diseases
The Official Journal of Qazvin University of Medical Sciences
Seroprevalence of Anti-SARS-CoV-2 IgG Antibody in Healthcare Workers: A Report From Rafsanjan City
Authors
Abstract
Background: Healthcare workers (HCWs) have a high risk of catching SARS-CoV-2 infection. Seroprevalence studies can provide related data on HCWs with a history of infections. Despite numerous seroepidemiological reports of COVID-19 in different groups, there are no such reports for HCWs working in Rafsanjan City, Iran. This study aimed to determine the SARS-CoV-2 seroprevalence among HCWs. Methods: Blood samples were obtained from 295 participants, including healthcare personnel and administrative staff. The SARS-CoV-2 IgG antibody was measured by the ELISA method, and the obtained data were analyzed with the Chi-square test and logistic regression. A P<0.05 was considered statistically significant. Results: The previous exposure to COVID-19 was higher in HCWs than in administrative department staff. Fifteen out of 130 (11.5%) participants had experienced SARS-CoV-2 infection without any symptoms. The results of logistic regression indicated that traveling (OR: 018, 95% CI: 0.08–0.74, P=0.001), occupation (OR: 0.2, 95% CI: 0.01–0.94, P<0.05), history of respiratory problems (OR: 0.15, 95% CI: 0.01–1.94, P<0.05), and major clinical signs (OR: 8.09, 95% CI: 3.7-17.66, P<0.001) are important factors which affect SARS-CoV-2 IgG antibodies. Conclusion: Our results indicated an occupational risk for SARS-CoV-2 infection among HCWs. Because some HCWs are asymptomatic, their communication, such as traveling, must be controlled, and it is necessary to ensure the safety of HCWs and reduce their transfer to the community and patients.
Copyright
© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
Prevalence of Anti-SARS-CoV-2 Antibody in Hospital Staff in Double-Center Setting: A Preliminary Report of a Cohort Study From Iran
Bagheri Lankarani K, Honarvar B, Omidifar N, Pakdin M, Moghadami M, et al. Prevalence of Anti-SARS-CoV-2 Antibody in Hospital Staff in Double-Center Setting: A Preliminary Report of a Cohort Study From Iran. Shiraz E-Med J. 2021;22(3):e112681. doi: https://doi.org/10.5812/semj.112681
Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Asymptomatic Healthcare Workers of Dezful Ganjavian Hospital, Southwest Iran
Mashayekhi A, Bashirkhabaz M, Pourmotahari F, Reyhani R, Alebakhit S, et al. Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Asymptomatic Healthcare Workers of Dezful Ganjavian Hospital, Southwest Iran. J Adv Immunopharmacol. 2024;4(1):e146101. doi: https://doi.org/10.5812/jai-146101
SARS-CoV-2 Antibodies in the Public Hospital Staff: The Second Report of a Seroprevalence Cohort Study from Iran
Amanat A, Bagheri Lankarani K, Honarvar B, Asmarian N, Shokripour M, et al. SARS-CoV-2 Antibodies in the Public Hospital Staff: The Second Report of a Seroprevalence Cohort Study from Iran. Shiraz E-Med J. 2022;23(9):e121681. doi: https://doi.org/10.5812/semj-121681
Seroprevalence of Anti-SARS-CoV-2 Antibodies in High-Risk Occupational and Low-Risk Groups in Southwestern Iran
Aliabadi N, Heydari Marandi N, Jamalidoust M, Ashkan Z, Pouladfar G, et al. Seroprevalence of Anti-SARS-CoV-2 Antibodies in High-Risk Occupational and Low-Risk Groups in Southwestern Iran. Jundishapur J Microbiol. 2022;15(7):e126975. doi: https://doi.org/10.5812/jjm-126975
Prevalence and Clinical Presentation of COVID 19 in Health Care Workers in Two Main Hospitals During the Pandemic in Shiraz, Iran
Jamalidoust M, Ashkan Z, Pouladfar G, Asaei S, Aliabadi N, et al. Prevalence and Clinical Presentation of COVID 19 in Health Care Workers in Two Main Hospitals During the Pandemic in Shiraz, Iran. Arch Pediatr Infect Dis. 2022;10(4):e121753. doi: https://doi.org/10.5812/pedinfect-121753
More by these authors
- Scopus by DOI: 0
Last Update: 1 month ago
- Scopus by Title: 0
Last Update: 1 month ago
- Scopus by Title (Ref): 0
Last Update: 1 month ago
- CrossRef: 0
Last Update: 6 days ago